| Literature DB >> 34232460 |
Jan-Per Wenzel1,2, Elina Petersen3, Julius Nikorowitsch4, Jessica Müller3, Tilo Kölbel5, Hermann Reichenspurner6,7, Stefan Blankenberg4,6,3, Evaldas Girdauskas6,7.
Abstract
To evaluate the prevalence of aortic regurgitation (AR) and associations between the individual aortic root components and AR severity in the general population. The study included the first 10,000 participants of the population-based Hamburg City Health Study (HCHS) of whom 8259 subjects, aged 62.23 ± 8.46 years (51.3% females), enrolled 2016-2018, provided echocardiographic data. 69 subjects with bicuspid valves and 23 subjects with moderate/severe aortic stenosis were excluded. Aortic root dimensions were measured using state-of-the-art cardiac ultrasound, including the aortic annulus, sinus of Valsalva, sinotubular junction (STJ), and ascending aorta, in diastole and systole. The distribution of AR was: 932 (11.4%) mild, 208 (2.5%) moderate, and 20 (0.24%) severe. Patients with moderate or severe AR were predominantly male at advanced age who had hypertension, coronary artery disease, atrial fibrillation, and renal dysfunction. Increasing AR severity correlated with higher absolute and indexed aortic root diameters (e.g., end-diastolic sinus of Valsalva for no-mild-moderate-severe AR in mm ± standard deviation: 34.06 ± 3.81; 35.65 ± 4.13; 36.13 ± 4.74; 39.67 ± 4.61; p < 0.001). In binary logistic regression analysis, all aortic root components showed significant associations with moderate/severe AR. Mid-systolic STJ showed the strongest association with moderate/severe AR (OR 1.33, 95% confidence interval 1.25-1.43, p < 0.001). AR was prevalent in 14.2%, of whom 2.8% showed moderate/severe AR. All assessed aortic root diameters correlated with the prevalence and severity of AR. STJ diameter had the strongest association with moderate/severe AR possibly reflecting the pathophysiological impact of an increasingly dilated STJ in the context of an ageing aorta.Entities:
Keywords: Aortic annulus; Aortic regurgitation; Aortic root; Echocardiography; Hamburg City Health Study; Sinotubular junction
Mesh:
Year: 2021 PMID: 34232460 PMCID: PMC8604845 DOI: 10.1007/s10554-021-02337-6
Source DB: PubMed Journal: Int J Cardiovasc Imaging ISSN: 1569-5794 Impact factor: 2.357
Baseline Characteristics of the study population stratified by AR severity
| No AR (n = 7007) | Mild AR (n = 932) | Moderate/Severe AR (n = 228) | p-value | |
|---|---|---|---|---|
| Demographics and biological data | ||||
| Age, years | 61.6 ± 8.4 | 66.0 + 7.8 | 67.3 ± 7.4 | < 0.001 |
| Male | 3369 (48.1) | 482 (51.7) | 125 (54.8) | 0.019 |
| Weight, kg | 78.6 ± 16.2 | 78.1 ± 15.3 | 77.5 ± 16.5 | 0.423 |
| Height, cm | 171.3 ± 9.5 | 171.2 ± 9.3 | 170.3 ± 9.9 | 0.359 |
| BSA, m2 | 1.9 ± 0.2 | 1.9 ± 0.2 | 1.9 ± 0.2 | 0.34 |
| Systolic blood pressure, mmHg | 138.4 ± 19.2 | 140.9 ± 19.6 | 143.5 ± 18.4 | < 0.001 |
| Heart rate, bpm | 69.8 ± 11.2 | 69.1 ± 10.5 | 69.6 ± 11.9 | 0.208 |
| Current smoking | 1438 (20.6) | 114 (12.3) | 32 (14.1) | < 0.001 |
| NYHA, II/III | 542 (8.6) | 84 (10.0) | 20 (10.5) | 0.267 |
| Comorbidities | ||||
| Hypertension | 4292 (64.7) | 638 (70.3) | 171 (78.1) | < 0.001 |
| Diabetes | 546 ( 8.5) | 68 ( 7.7) | 17 (7.9) | 0.728 |
| Coronary artery disease | 291 (5.9) | 45 (6.9) | 23 (14.9) | < 0.001 |
| Atrial fibrillation | 341 (5.4) | 75 (8.9) | 28 (13.4) | < 0.001 |
| Peripheral artery disease | 207 ( 3.2) | 41 ( 4.9) | 8 (4.1) | 0.042 |
| Medication | ||||
| Beta-blockers | 1114 (16.7) | 180 (20.0) | 51 (23.3) | 0.003 |
| Diuretics | 152 (2.3) | 28 (3.1) | 8 (3.7) | 0.15 |
| Statines | 1132 (17.0) | 182 (20.3) | 53 (24.2) | 0.002 |
| ACE/AT-I-antagonists | 1356 (20.4) | 207 (23.1) | 63 (28.8) | 0.003 |
| Laboratories | ||||
| LDL, mg/dl | 121.0 [96.0, 146.0] | 118.0 [93.0, 143.0] | 119.0 [96.0, 150.0] | 0.058 |
| GFR, ml/min | 86.3 [75.5, 94.7] | 83.1 [71.9, 90.7] | 81.7 [71.4, 88.2] | < 0.001 |
| NT-proBNP, ng/l | 77.0 [43.0, 141.0] | 100.0 [54.3, 179.5] | 136.0 [79.0, 228.0] | < 0.001 |
| hsCRP,mg/l | 0.12 [0.06, 0.26] | 0.12 [0.06, 0.24] | 0.12 [0.06, 0.26] | 0.428 |
| Glucose, mg/dl | 92.0 [86.0, 100.0] | 92.0 [96.0, 99.0] | 93.0 [87.0, 100.0] | 0.562 |
Data are given as n (%) or mean ± standard deviation, p-value for intergroup differences
ACEi angiotensin-converting enzyme inhibitor, AR aortic regurgitation, ARB angiotensin receptor blocker, BMI body mass index, BSA body surface area, CAD coronary artery disease; hsCRP high sensitivity C-reactive protein, GFR glomerular filtration rate, NT-proBNP N-terminal pro-B-type natriuretic peptide, NYHA New York Heart Association
Fig. 1Study flow-chart. From a total of 8259 subjects providing echocardiographic data, 92 were excluded due more than mild aortic stenosis or bicuspid aortic valve. Consequently, 8167 subjects were included in the study analysis. Of those, 1160 subjects suffered from aortic regurgitation. The aortic root was systematically measured in end-diastole and mid-systole and the correlation between aortic root dimensions and the severity of aortic regurgitation was calculated. AR aortic regurgitation, HCHS Hamburg City Health Study, TTE transthoracic echocardiography
Echocardiographic findings of the study population stratified by AR severity
| No AR (n = 7007) | Mild AR (n = 932) | Moderate/Severe AR (n = 228) | p-value | |
|---|---|---|---|---|
| Concomitant valvular disease | ||||
| Mild AS | 86 (1.3) | 23 (2.8) | 7 (3.4) | < 0.001 |
| Moderate/severe MR | 189 (2.3) | 74 (7.9) | 19 (8.3) | < 0.001 |
| Moderate/severe TR | 623 (8.9) | 193 (20.7) | 46 (20.2) | < 0.001 |
| Echocardiographic data | ||||
| LVEF 2D, % | 58.5 ± 5.2 | 58.3 + 5.0 | 57.6 ± 5.6 | 0.045 |
| LVEF 3D, % | 59.6 ± 6.8 | 59.2 ± 6.6 | 58.3 ± 6.8 | 0.178 |
| LVEDD, mm | 47.7 ± 5.2 | 47.9 ± 5.3 | 48.9 ± 6.4 | 0.004 |
| LVEDV, ml | 114.9 ± 31.8 | 108.4 ± 30.6 | 118.9 ± 34.6 | < 0.001 |
| TAPSE, mm | 24.4 ± 4.3 | 23.8 ± 4.4 | 23.4 ± 4.2 | 0.001 |
| RV FAC, % | 43.2 ± 8.0 | 43.7 ± 7.7 | 42.7 ± 8.4 | 0.217 |
| IVSD, mm | 9.9 ± 1.7 | 10.3 ± 1.8 | 10.7 ± 1.9 | < 0.001 |
| E/e ‘ | 7.6 ± 2.1 | 7.8 ± 2.4 | 8.5 ± 2.9 | < 0.001 |
| LAVI, ml/m2 | 27.5 ± 8.4 | 27.9 ± 8.9 | 30.2 ± 10.8 | < 0.001 |
| LA Global Peak strain, % | 39.8 ± 14.4 | 38.5 ± 15.4 | 37.0 ± 14.5 | 0.014 |
Data are given as n (%) or mean ± standard deviation, p-value for intergroup differences. All subjects with moderate/severe aortic stenosis or bicuspid valves were excluded from the analysis
AS aortic stenosis, IVST interventricular septum thickness, LA left atrial, LAVI left atrial volume index, LVEDD left ventricular end-diastolic diameter, LVEDV left ventricular end-diastolic volume, LVEF left ventricular ejection fraction, MR mitral regurgitation, MS mitral stenosis, RV FAC right ventricular fractional area change, TAPSE tricuspid annular peak systolic excursion, TR tricuspid regurgitation
Aortic root diameters absolute (mm) and indexed to body surface area (mm/m2) in relation to AR severity
| None (n = 7007) | Mild AR (n = 932) | Moderate AR (n = 208) | Severe AR (n = 20) | p-value | |
|---|---|---|---|---|---|
| Absolute | |||||
| ED Ao annulus | 20.33 ± 1.71 | 20.65 ± 1.84 | 20.50 + 2.01 | 22.26 ± 1.91 | < 0.001 |
| MS Ao annulus | 20.96 ± 1.76 | 21.35 ± 1.87 | 21.29 ± 1.98 | 22.19 ± 1.85 | < 0.001 |
| ED Ao sinus | 34.06 ± 3.81 | 35.65 ± 4.13 | 36.13 ± 4.74 | 39.67 ± 4.61 | < 0.001 |
| MS Ao sinus | 35.02 ± 3.82 | 36.15 ± 4.16 | 37.16 ± 4.69 | 40.88 ± 3.68 | < 0.001 |
| ED Ao STJ | 26.53 ± 3.07 | 27.70 ± 3.25 | 28.33 ± 3.63 | 31.22 ± 3.27 | < 0.001 |
| MS Ao STJ | 27.63 ± 3.24 | 29.01 ± 3.62 | 30.07 ± 3.80 | 33.65 ± 3.81 | < 0.001 |
| ED Asc Ao | 29.94 ± 3.77 | 30.96 ± 4.11 | 32.56 ± 4.65 | 36.03 ± 3.43 | < 0.001 |
| MS Asc Ao | 29.94 ± 3.51 | 30.99 ± 3.81 | 32.57 ± 4.12 | 35.67 ± 3.37 | < 0.001 |
| Indexed to BSA | |||||
| ED Ao annulus | 10.79 ± 1.09 | 10.97 ± 1.08 | 11.03 ± 1.15 | 12.18 ± 1.25 | < 0.001 |
| MS Ao annulus | 11.09 ± 1.08 | 11.32 ± 1.05 | 11.35 ± 1.20 | 12.00 ± 1.15 | < 0.001 |
| ED Ao sinus | 18.01 ± 1.99 | 18.86 ± 2.06 | 19.18 ± 2.38 | 21.39 ± 1.75 | < 0.001 |
| MS Ao sinus | 18.54 ± 2.04 | 19.23 ± 2.10 | 19.69 ± 2.38 | 22.30 ± 1.63 | < 0.001 |
| ED Ao STJ | 14.03 ± 1.66 | 14.68 ± 1.77 | 14.99 ± 2.00 | 16.75 ± 1.55 | < 0.001 |
| MS Ao STJ | 14.65 ± 1.73 | 15.42 ± 1.84 | 15.98 ± 2.10 | 18.28 ± 1.62 | < 0.001 |
| ED Asc Ao | 15.79 ± 2.08 | 16.40 ± 2.17 | 17.10 ± 2.42 | 19.56 ± 2.40 | < 0.001 |
| MS Asc Ao | 15.82 ± 1.96 | 16.48 ± 1.89 | 17.26 ± 2.04 | 19.41 ± 1.29 | < 0.001 |
Data are given as mean ± standard deviation, p-value for intergroup differences
AR aortic regurgitation, Asc ascending, Ao Aortic/Aorta, BSA Body surface area, ED end-diastolic, MS mid-systolic, STJ sinotubular junction
Fig. 2Correlation of AR severity with the sinotubular junction indexed to BSA as well as the ratio of sinotubular junction indexed and aortic annulus indexed to BSA. p-values for inter-group differences. Ao Ann Aortic annulus, BSA body surface area, STJ sinotubular junction
Odds ratios and 95%-CIs derived from univariate and multivariate regression analysis for the associations of aortic root measurements with moderate/severe AR
| Univariate | Multivariate | |||
|---|---|---|---|---|
| OR [95% CI] | p-value | OR [95% CI] | p-value | |
| End-diastolic aortic root measurements | ||||
| Ao Ann ED | 1.11 [1.02–1.21] | 0.016 | 1.17 [1.05–1.32] | 0.013 |
| Age | 1.09 [1.06–1.11] | < 0.001 | ||
| Male sex | 1.15 [0.72–1.85] | 1.000 | ||
| BSA | 0.21 [0.07–0.67] | 0.070 | ||
| Hypertension | 1.54 [1–2.42] | 0.331 | ||
| Diabetes | 0.89 [0.56–1.34] | 1.000 | ||
| Ao Sinus ED | 1.16 [1.12–1.2] | < 0.001 | 1.19 [1.14–1.25] | < 0.001 |
| Age | 1.07 [1.04–1.09] | < 0.001 | ||
| Male sex | 0.81 [0.52–1.27] | 1.000 | ||
| BSA | 0.17 [0.06–0.46] | 0.006 | ||
| Hypertension | 1.76 [1.19–2.68] | 0.063 | ||
| Diabetes | 0.83 [0.53–1.22] | 1.000 | ||
| Ao STJ ED | 1.24 [1.17–1.3] | < 0.001 | 1.26 [1.18–1.34] | < 0.001 |
| Age | 1.08 [1.05–1.11] | < 0.001 | ||
| Male sex | 0.93 [0.58–1.49] | 1.000 | ||
| BSA | 0.2 [0.06–0.62] | 0.049 | ||
| Hypertension | 1.5 [0.98–2.35] | 0.360 | ||
| Diabetes | 0.91 [0.57–1.38] | 1.000 | ||
| Ao Asc ED | 1.2 [1.15–1.26] | < 0.001 | 1.2 [1.14–1.27] | < 0.001 |
| Age | 1.07 [1.04–1.1] | < 0.001 | ||
| Male sex | 0.86 [0.5–1.47] | 1.000 | ||
| BSA | 0.27 [0.07–1] | 0.206 | ||
| Hypertension | 1.68 [0.97–3.09] | 0.360 | ||
| Diabetes | 0.9 [0.52–1.45] | 1.000 | ||
| Mid-systolic aortic root measurements | ||||
| Ao Ann MS | 1.16 [1.07–1.26] | < 0.001 | 1.25 [1.11–1.4] | 0.002 |
| Age | 1.08 [1.05–1.1] | < 0.001 | ||
| Male sex | 1.01 [0.65–1.55] | 1.000 | ||
| BSA | 0.26 [0.09–0.74] | 0.070 | ||
| Hypertension | 1.66 [1.12–2.54] | 0.132 | ||
| Diabetes | 0.85 [0.55–1.24] | 1.000 | ||
| Ao Sinus MS | 1.17 [1.12–1.22] | < 0.001 | 1.2 [1.14–1.27] | < 0.001 |
| Age | 1.08 [1.05–1.11] | < 0.001 | ||
| Male sex | 0.74 [0.44–1.27] | 1.000 | ||
| BSA | 0.2 [0.06–0.68] | 0.070 | ||
| Hypertension | 1.71 [1.07–2.83] | 0.209 | ||
| Diabetes | 0.9 [0.53–1.41] | 1.000 | ||
| Ao STJ MS | 1.26 [1.19–1.32] | < 0.001 | 1.33 [1.25–1.43] | < 0.001 |
| Age | 1.08 [1.04–1.11] | < 0.001 | ||
| Male sex | 0.57 [0.32–1.04] | 0.671 | ||
| BSA | 0.15 [0.04–0.61] | 0.070 | ||
| Hypertension | 2.01 [1.16–3.68] | 0.137 | ||
| Diabetes | 0.98 [0.54–1.62] | 1.000 | ||
| Ao Asc MS | 1.23 [1.16–1.3] | < 0.001 | 1.26 [1.17–1.35] | < 0.001 |
| Age | 1.08 [1.04–1.12] | < 0.001 | ||
| Male sex | 0.73 [0.38–1.42] | 1.000 | ||
| BSA | 0.2 [0.04–1] | 0.206 | ||
| Hypertension | 1.4 [0.76–2.74] | 0.905 | ||
| Diabetes | 1.05 [0.52–1.89] | 1.000 | ||
P-values were corrected for multiple testing using the post-hoc Holm method
Ao aortic, AR aortic regurgitation, Asc ascending, BSA body surface area; CI confidence interval, ED end-diastolic, MS mid-systolic, OR odds ratio, STJ sinotubular junction
Fig. 3Associations between aortic root dimensions and moderate/severe aortic regurgitation derived from multivariate logistic regression analysis. Odds ratios derived from multivariate logistic regression analysis adjusted for age, sex, body surface area, hypertension, and diabetes with Holm corrected p-values. Squares and horizontal lines represent odds ratios and 95% confidence intervals. Ao aortic, AR aortic regurgitation, Asc ascending, CI confidence interval, ED end-diastolic, MS mid-systolic, OR odds ratio, STJ sinotubular junction